Total Payments
$840.14
2024 Payments
$125.71
Companies
13
Transactions
34
Medicare Patients
703
Medicare Billing
$32,574
Payment Breakdown by Category
Food & Beverage$651.86 (77.6%)
Education$188.28 (22.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $651.86 | 31 | 77.6% |
| Education | $188.28 | 3 | 22.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $260.18 | 8 | $0 (2019) |
| CardioFocus, Inc. | $160.90 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $133.00 | 8 | $0 (2024) |
| PFIZER INC. | $68.05 | 4 | $0 (2024) |
| Novo Nordisk Inc | $39.29 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $34.76 | 2 | $0 (2018) |
| Lilly USA, LLC | $31.44 | 2 | $0 (2024) |
| Kyowa Kirin, Inc. | $26.00 | 1 | $0 (2024) |
| Abbott Laboratories | $23.96 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $19.98 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.71 | 6 | Novo Nordisk Inc ($39.29) |
| 2023 | $23.96 | 1 | Abbott Laboratories ($23.96) |
| 2022 | $13.30 | 1 | Lilly USA, LLC ($13.30) |
| 2021 | $21.64 | 1 | PFIZER INC. ($21.64) |
| 2019 | $90.52 | 6 | Endogastric Solutions, Inc ($17.55) |
| 2018 | $442.19 | 11 | Astellas Pharma US Inc ($196.94) |
| 2017 | $122.82 | 8 | GlaxoSmithKline, LLC. ($46.34) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Obesity | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: VACCINES | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes | ||||||
| 08/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Diabetes Care | ||||||
| 06/20/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $13.30 | General |
| 11/03/2021 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: VACCINES | ||||||
| 09/11/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2019 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: GERD | ||||||
| 07/11/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: UROLOGY | ||||||
| 04/18/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: RESPIRATORY | ||||||
| 02/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 10/16/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 07/18/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2018 | CardioFocus, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.68 | General |
| Category: ATRIAL FIBRILLATION | ||||||
| 04/26/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: UROLOGY | ||||||
| 03/26/2018 | CardioFocus, Inc. | — | Food and Beverage | Cash or cash equivalent | $125.22 | General |
| Category: ATRIAL FIBRILLATION | ||||||
| 03/14/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: UROLOGY | ||||||
| 03/13/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 171 | 231 | $46,066 | $12,228 |
| 2022 | 5 | 95 | 143 | $24,618 | $5,840 |
| 2021 | 8 | 388 | 475 | $52,447 | $14,292 |
| 2020 | 2 | 49 | 60 | $847.20 | $214.28 |
Total Patients
703
Total Services
909
Medicare Billing
$32,574
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 36 | 36 | $15,768 | $4,497 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 64 | $13,665 | $3,653 | 26.7% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 36 | 36 | $4,320 | $1,377 | 31.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 16 | $6,469 | $1,308 | 20.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 22 | 24 | $5,131 | $1,249 | 24.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 41 | $378.84 | $90.20 | 23.8% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 14 | 14 | $334.32 | $52.80 | 15.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 61 | $13,024 | $3,149 | 24.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 16 | $6,469 | $1,475 | 22.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 21 | $4,490 | $1,095 | 24.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 30 | $277.20 | $66.54 | 24.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 15 | 15 | $358.20 | $55.00 | 15.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 101 | $21,565 | $5,294 | 24.5% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 110 | 110 | $9,350 | $3,096 | 33.1% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 119 | 119 | $6,069 | $2,343 | 38.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 26 | 29 | $6,200 | $1,525 | 24.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $6,065 | $1,108 | 18.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 27 | 27 | $2,295 | $733.59 | 32.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 48 | 59 | $545.16 | $132.75 | 24.4% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 14 | 15 | $358.20 | $59.76 | 16.7% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2020 | 18 | 20 | $477.60 | $124.88 | 26.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 31 | 40 | $369.60 | $89.40 | 24.2% |
About Dr. Christopher Teague, MD
Dr. Christopher Teague, MD is a Family Medicine healthcare provider based in Hillsboro, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821064486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Teague, MD has received a total of $840.14 in payments from pharmaceutical and medical device companies, with $125.71 received in 2024. These payments were reported across 34 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($651.86).
As a Medicare-enrolled provider, Teague has provided services to 703 Medicare beneficiaries, totaling 909 services with total Medicare billing of $32,574. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hillsboro, TX
- Active Since 02/24/2006
- Last Updated 01/09/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821064486
Products in Payments
- BREO (Drug) $53.45
- Myrbetriq (Drug) $45.74
- MYRBETRIQ (Drug) $39.46
- FARXIGA (Drug) $34.76
- TRELEGY ELLIPTA (Drug) $32.83
- Crysvita (Drug) $26.00
- ANORO (Drug) $25.64
- FREESTYLE LIBRE 3 (Device) $23.96
- PREVNAR 13 (Biological) $21.64
- PREVNAR 20 (Biological) $21.20
- AREXVY (Drug) $21.08
- Ozempic (Drug) $20.27
- ENTRESTO (Drug) $19.98
- Wegovy (Drug) $19.02
- MOUNJARO (Drug) $18.14
- ESOPHYX (Device) $17.55
- ELIQUIS (Drug) $14.45
- SPIRIVA RESPIMAT (Drug) $13.38
- LINZESS (Drug) $11.65
- TRUMENBA (Biological) $10.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hillsboro
Dr. David Stansfield, Do, DO
Family Medicine — Payments: $10,120
Family Medicine $10,120
Dr. Danielle Shapiro, Md, MD
Family Medicine — Payments: $6,386
Family Medicine $6,386
Jacob Yankowitz, Do, DO
Family Medicine — Payments: $4,506
Family Medicine $4,506
Traci Ackron, D.o, D.O
Family Medicine — Payments: $3,715
Family Medicine $3,715
Timothy Luithle, Md, MD
Family Medicine — Payments: $2,472
Family Medicine $2,472
Dr. Matthew Studebaker, M.d, M.D
Family Medicine — Payments: $2,463
Family Medicine $2,463